SUSTAINED-RELEASE TABLET CONTAINING SOLUBILIZED NIFLUMIC ACID

PURPOSE: A sustained release tablet containing niflumic acid is provided to enhance release rate of the niflumic acid and treatment effect. CONSTITUTION: A pharmaceutical formulation containing niflumic acid contains niflumic acid and solide dispersion of water soluble polymer. The water soluble pol...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WOO, SEOK JE, CHO, HONG KOO, GIL, YOUNG SIG, AHN, KI YOUNG
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PURPOSE: A sustained release tablet containing niflumic acid is provided to enhance release rate of the niflumic acid and treatment effect. CONSTITUTION: A pharmaceutical formulation containing niflumic acid contains niflumic acid and solide dispersion of water soluble polymer. The water soluble polymer is polyvinylpyrrolidone. The content of the polyvinylpyrrolidone is 0.2~1.5 weight parts. The pharmaceutical formulation is hydroxypropylmethylcellulose, polymethacrylate, or sustained release tablet containing them.